NOX 14.3% 12.0¢ noxopharm limited

From a recent announcement:Treatments that stop patients...

  1. 405 Posts.
    lightbulb Created with Sketch. 56
    From a recent announcement:
    Treatments that stop patients progressing into needing high-level health care such as mechanical
    ventilation and occupying ICU beds is a major industry goal. Our confidence is growing that
    Veyonda will form part of meeting that goal, and in so doing, potentially save many lives and
    deliver shareholders a potentially highly valuable and much sought after asset.”

    As the drug has been proven to have no harmful effects why not trial it in India? Hundreds
    /thousands are dying through lack of oxygen and ventilators.

 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
12.0¢
Change
0.015(14.3%)
Mkt cap ! $33.60M
Open High Low Value Volume
12.5¢ 14.0¢ 11.0¢ $556.7K 4.461M

Buyers (Bids)

No. Vol. Price($)
6 681590 11.0¢
 

Sellers (Offers)

Price($) Vol. No.
12.0¢ 99714 1
View Market Depth
Last trade - 15.57pm 03/09/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.